6·3% of those who had taken metformin while infected with the SARS-CoV-2 ended up getting diagnosed with long Covid versus 10.4% of those who had received placebo only.
6·3% of those who had taken metformin while infected with the SARS-CoV-2 ended up getting diagnosed with long Covid versus 10.4% of those who had received placebo only.